0000920465-19-000183.txt : 20191223
0000920465-19-000183.hdr.sgml : 20191223
20191223160938
ACCESSION NUMBER: 0000920465-19-000183
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191220
FILED AS OF DATE: 20191223
DATE AS OF CHANGE: 20191223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAMSAY DAVID A
CENTRAL INDEX KEY: 0001283292
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 191306100
MAIL ADDRESS:
STREET 1: HALOZYME THERAPEUTICS, INC.
STREET 2: 11588 SORRENTO VALLEY ROAD, #17
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_157713535980757.xml
FORM 4
X0306
4
2019-12-20
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001283292
RAMSAY DAVID A
C/O LA JOLLA PHARMACEUTICAL COMPANY
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (Right to Buy)
3.93
2019-12-20
4
A
0
12000
0
A
2029-12-20
Common Stock
12000.0
12000
D
1. This option represents a right to purchase a total of 12,000 shares of the Issuer's Common Stock which shall be fully vested and exercisable on December 20, 2020.
/s/ Ryan Murr, by power of attorney for David A. Ramsay
2019-12-23